Oncology Central

Nanoparticle-based cisplatin therapy for cancer


Cisplatin, a platinum based compound is one of the most potent and widely used chemotherapeutic drugs for cancer treatment. Cisplatin was an accidental discovery made by Dr. Barnett Rosenberg at Michigan State University, United States of America in 1965 [1]. His initial observation was that cisplatin inhibited cell division of Escherichia coli. This finding led to testing of cisplatin against human cancer cells both in vitro and in vivo and demonstration of the potency of cisplatin as an anticancer agent.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.